Five-Year Incidence of Visual Impairment in Middle-Aged Iranians: The Shahroud Eye Cohort Study
Purpose: To study the 5-year incidence of visual impairment and its causes and risk factors, in the middle-aged Iranian sample of the Shahroud Eye Cohort Study (ShECS). Methods: Data from subjects who had participated in both phases of the ShECS were used to determine age- and sex-specific incidence...
Saved in:
Published in | Ophthalmic epidemiology Vol. 24; no. 1; pp. 11 - 16 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
Taylor & Francis
01.02.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Purpose: To study the 5-year incidence of visual impairment and its causes and risk factors, in the middle-aged Iranian sample of the Shahroud Eye Cohort Study (ShECS).
Methods: Data from subjects who had participated in both phases of the ShECS were used to determine age- and sex-specific incidence rates of visual impairment using the World Health Organization (WHO) definitions for bilateral low vision (visual acuity, VA, >0.5 and ≤1.3 LogMAR in the better eye) and blindness (VA worse than 1.3 LogMAR in the better eye). Risk ratios (RR) and 95% confidence intervals (CIs) were calculated using multivariable log-binomial regression.
Results: Of the 5079 ShECS I survivors, 4737 (93.3%) completed the 5-year follow-up. Their mean age at baseline was 50.9 ± 6.2 years, and 58.9% were female. The incidence of visual impairment was 1.12% (95% CI 0.82-1.42%) by presenting VA and 0.19% (95% CI 0.07-0.32%) by best-corrected VA; leading causes of the former were uncorrected refractive error (81.3%) and diabetic retinopathy (15.1%). In the multivariable model, risk factors for incident visual impairment by presenting VA were older age (RR 1.05, p = 0.044), lower education (RR 0.89, p = 0.002), and diabetes (RR 3.74, p < 0.001).
Conclusion: This is the first incidence study of visual impairment in a middle-aged Iranian population. Since age is a major risk factor, the number of visually impaired is expected to increase as the population ages, and less treatable causes such as diabetic retinopathy begin to surface. Measures for tackling uncorrected refractive error and enhancing diabetes screening and preventive programs are recommended. |
---|---|
AbstractList | To study the 5-year incidence of visual impairment and its causes and risk factors, in the middle-aged Iranian sample of the Shahroud Eye Cohort Study (ShECS).PURPOSETo study the 5-year incidence of visual impairment and its causes and risk factors, in the middle-aged Iranian sample of the Shahroud Eye Cohort Study (ShECS).Data from subjects who had participated in both phases of the ShECS were used to determine age- and sex-specific incidence rates of visual impairment using the World Health Organization (WHO) definitions for bilateral low vision (visual acuity, VA, >0.5 and ≤1.3 LogMAR in the better eye) and blindness (VA worse than 1.3 LogMAR in the better eye). Risk ratios (RR) and 95% confidence intervals (CIs) were calculated using multivariable log-binomial regression.METHODSData from subjects who had participated in both phases of the ShECS were used to determine age- and sex-specific incidence rates of visual impairment using the World Health Organization (WHO) definitions for bilateral low vision (visual acuity, VA, >0.5 and ≤1.3 LogMAR in the better eye) and blindness (VA worse than 1.3 LogMAR in the better eye). Risk ratios (RR) and 95% confidence intervals (CIs) were calculated using multivariable log-binomial regression.Of the 5079 ShECS I survivors, 4737 (93.3%) completed the 5-year follow-up. Their mean age at baseline was 50.9 ± 6.2 years, and 58.9% were female. The incidence of visual impairment was 1.12% (95% CI 0.82-1.42%) by presenting VA and 0.19% (95% CI 0.07-0.32%) by best-corrected VA; leading causes of the former were uncorrected refractive error (81.3%) and diabetic retinopathy (15.1%). In the multivariable model, risk factors for incident visual impairment by presenting VA were older age (RR 1.05, p = 0.044), lower education (RR 0.89, p = 0.002), and diabetes (RR 3.74, p < 0.001).RESULTSOf the 5079 ShECS I survivors, 4737 (93.3%) completed the 5-year follow-up. Their mean age at baseline was 50.9 ± 6.2 years, and 58.9% were female. The incidence of visual impairment was 1.12% (95% CI 0.82-1.42%) by presenting VA and 0.19% (95% CI 0.07-0.32%) by best-corrected VA; leading causes of the former were uncorrected refractive error (81.3%) and diabetic retinopathy (15.1%). In the multivariable model, risk factors for incident visual impairment by presenting VA were older age (RR 1.05, p = 0.044), lower education (RR 0.89, p = 0.002), and diabetes (RR 3.74, p < 0.001).This is the first incidence study of visual impairment in a middle-aged Iranian population. Since age is a major risk factor, the number of visually impaired is expected to increase as the population ages, and less treatable causes such as diabetic retinopathy begin to surface. Measures for tackling uncorrected refractive error and enhancing diabetes screening and preventive programs are recommended.CONCLUSIONThis is the first incidence study of visual impairment in a middle-aged Iranian population. Since age is a major risk factor, the number of visually impaired is expected to increase as the population ages, and less treatable causes such as diabetic retinopathy begin to surface. Measures for tackling uncorrected refractive error and enhancing diabetes screening and preventive programs are recommended. To study the 5-year incidence of visual impairment and its causes and risk factors, in the middle-aged Iranian sample of the Shahroud Eye Cohort Study (ShECS). Data from subjects who had participated in both phases of the ShECS were used to determine age- and sex-specific incidence rates of visual impairment using the World Health Organization (WHO) definitions for bilateral low vision (visual acuity, VA, >0.5 and ≤1.3 LogMAR in the better eye) and blindness (VA worse than 1.3 LogMAR in the better eye). Risk ratios (RR) and 95% confidence intervals (CIs) were calculated using multivariable log-binomial regression. Of the 5079 ShECS I survivors, 4737 (93.3%) completed the 5-year follow-up. Their mean age at baseline was 50.9 ± 6.2 years, and 58.9% were female. The incidence of visual impairment was 1.12% (95% CI 0.82-1.42%) by presenting VA and 0.19% (95% CI 0.07-0.32%) by best-corrected VA; leading causes of the former were uncorrected refractive error (81.3%) and diabetic retinopathy (15.1%). In the multivariable model, risk factors for incident visual impairment by presenting VA were older age (RR 1.05, p = 0.044), lower education (RR 0.89, p = 0.002), and diabetes (RR 3.74, p < 0.001). This is the first incidence study of visual impairment in a middle-aged Iranian population. Since age is a major risk factor, the number of visually impaired is expected to increase as the population ages, and less treatable causes such as diabetic retinopathy begin to surface. Measures for tackling uncorrected refractive error and enhancing diabetes screening and preventive programs are recommended. Purpose: To study the 5-year incidence of visual impairment and its causes and risk factors, in the middle-aged Iranian sample of the Shahroud Eye Cohort Study (ShECS). Methods: Data from subjects who had participated in both phases of the ShECS were used to determine age- and sex-specific incidence rates of visual impairment using the World Health Organization (WHO) definitions for bilateral low vision (visual acuity, VA, >0.5 and ≤1.3 LogMAR in the better eye) and blindness (VA worse than 1.3 LogMAR in the better eye). Risk ratios (RR) and 95% confidence intervals (CIs) were calculated using multivariable log-binomial regression. Results: Of the 5079 ShECS I survivors, 4737 (93.3%) completed the 5-year follow-up. Their mean age at baseline was 50.9 ± 6.2 years, and 58.9% were female. The incidence of visual impairment was 1.12% (95% CI 0.82-1.42%) by presenting VA and 0.19% (95% CI 0.07-0.32%) by best-corrected VA; leading causes of the former were uncorrected refractive error (81.3%) and diabetic retinopathy (15.1%). In the multivariable model, risk factors for incident visual impairment by presenting VA were older age (RR 1.05, p = 0.044), lower education (RR 0.89, p = 0.002), and diabetes (RR 3.74, p < 0.001). Conclusion: This is the first incidence study of visual impairment in a middle-aged Iranian population. Since age is a major risk factor, the number of visually impaired is expected to increase as the population ages, and less treatable causes such as diabetic retinopathy begin to surface. Measures for tackling uncorrected refractive error and enhancing diabetes screening and preventive programs are recommended. |
Author | Mehravaran, Shiva Hashemi, Hassan Emamian, Mohammad Hassan Fotouhi, Akbar |
Author_xml | – sequence: 1 givenname: Hassan surname: Hashemi fullname: Hashemi, Hassan organization: Noor Ophthalmology Research Center, Noor Eye Hospital – sequence: 2 givenname: Shiva surname: Mehravaran fullname: Mehravaran, Shiva organization: Noor Ophthalmology Research Center, Noor Eye Hospital – sequence: 3 givenname: Mohammad Hassan surname: Emamian fullname: Emamian, Mohammad Hassan organization: Department of Epidemiology, School of Public Health, Shahroud University of Medical Sciences – sequence: 4 givenname: Akbar surname: Fotouhi fullname: Fotouhi, Akbar email: afotouhi@tums.ac.ir organization: Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27960616$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkU1vGyEQhlGUKHE-fkIqjr2sA8vC4vTSyEoaS6l6SFKpJ4RhqIl2wQW2lf9917J96aE5zeV53hnNe46OQwyA0DUlU0okuSGzWgouxbQmVExpzTlr6iM0oW3TVJxIcYwmW6baQmfoPOc3QqgkXJyis7qdCSKomCD14H9D9QN0wotgvIVgAEeHv_s86A4v-rX2qYdQsA_4q7e2g-ruJ1i8SDp4HfItflkBfl7pVYqDxfcbwPO4iqng5zLYzSU6cbrLcLWfF-j14f5l_lg9ffuymN89VYYJUSo2a4G58SiwTnPhpBNUc4CG8JqL2hgCZtYysqQjzrlpGqIl1ZQuwRFpGLtAH3e56xR_DZCL6n020HU6QByyopLXoqUt4yP6YY8Oyx6sWiff67RRh6eMwKcdYFLMOYFTxhddfAwlad8pStS2AnWoQG0rUPsKRpv_Yx8WvOd93nk-uJh6_SemzqqiN11Mbny28Vmx_0f8BRKRmzI |
CitedBy_id | crossref_primary_10_1111_ceo_13431 crossref_primary_10_1016_j_xops_2023_100392 crossref_primary_10_1016_j_ijnss_2023_06_010 crossref_primary_10_1016_j_jdiacomp_2020_107560 crossref_primary_10_15171_ijhpm_2017_48 crossref_primary_10_1136_bjophthalmol_2021_320892 crossref_primary_10_1016_j_ajo_2020_09_035 |
Cites_doi | 10.1001/archopht.120.5.613 10.1016/j.ophtha.2012.11.041 10.1016/S0161-6420(01)00769-2 10.1111/1753-0407.12195 10.1016/S0039-6257(05)80092-X 10.1038/eye.2012.94 10.1167/iovs.13-11911 10.1136/bjo.86.2.238 10.1093/ije/dys161 10.1111/j.1755-3768.2008.01445.x 10.1016/S0161-6420(02)01898-5 10.1016/j.ophtha.2013.03.032 10.1016/j.ophtha.2010.09.032 10.1167/iovs.02-0457 10.1016/S0161-6420(02)01295-2 |
ContentType | Journal Article |
Copyright | 2017 Taylor & Francis Group, LLC 2017 |
Copyright_xml | – notice: 2017 Taylor & Francis Group, LLC 2017 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1080/09286586.2016.1255342 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1744-5086 |
EndPage | 16 |
ExternalDocumentID | 27960616 10_1080_09286586_2016_1255342 1255342 |
Genre | Article Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Shahroud University of Medical Sciences – fundername: Noor Ophthalmology Research Center |
GroupedDBID | --- 00X 03L 0BK 0R~ 123 29N 36B 4.4 53G AALUX AAMIU AAPUL AAPXX AAQRR ABBKH ABDBF ABEIZ ABJNI ABLIJ ABLKL ABUPF ABXYU ACENM ACGEJ ACGFS ACIEZ ACUHS ADCVX ADRBQ ADXPE AECIN AENEX AEOZL AFKVX AGDLA AGFJD AGRBW AGYJP AIJEM AIRBT AJWEG AKBVH ALMA_UNASSIGNED_HOLDINGS ALQZU ALYBC AMDAE BABNJ BLEHA BOHLJ CCCUG CS3 DKSSO DU5 EAP EBC EBD EBS EJD EMB EMK EMOBN EPL ESX F5P H13 HZ~ KRBQP KSSTO KWAYT KYCEM M4Z O9- P2P RNANH RVRKI SV3 TBQAZ TDBHL TERGH TFDNU TFL TFW TUROJ TUS UEQFS V1S ~1N AAGDL AAYXX ABWVI ADYSH AFRVT AMPGV CITATION 5VS AALIY AAORF ABWCV ABZEW ACKZS ADFOM ADFZZ AEIIZ AFFVI AFLEI AJVHN AWYRJ BRMBE CAG CGR COF CUY CVF CYYVM CZDIS DRXRE DWTOO ECM EIF JENTW LJTGL M44 NPM NUSFT QQXMO S70 7X8 TASJS |
ID | FETCH-LOGICAL-c366t-397e3f960edfa56f8f61a5ee4052562cc0ec9730b136655c440a81a11bef08c33 |
ISSN | 0928-6586 1744-5086 |
IngestDate | Sun Aug 24 04:21:41 EDT 2025 Wed Feb 19 02:40:54 EST 2025 Thu Apr 24 23:08:13 EDT 2025 Tue Jul 01 00:45:41 EDT 2025 Wed Dec 25 09:04:57 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | visual impairment Iran longitudinal incidence Blindness |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c366t-397e3f960edfa56f8f61a5ee4052562cc0ec9730b136655c440a81a11bef08c33 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 27960616 |
PQID | 1852671735 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | informaworld_taylorfrancis_310_1080_09286586_2016_1255342 crossref_citationtrail_10_1080_09286586_2016_1255342 crossref_primary_10_1080_09286586_2016_1255342 proquest_miscellaneous_1852671735 pubmed_primary_27960616 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-02-01 |
PublicationDateYYYYMMDD | 2017-02-01 |
PublicationDate_xml | – month: 02 year: 2017 text: 2017-02-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Ophthalmic epidemiology |
PublicationTitleAlternate | Ophthalmic Epidemiol |
PublicationYear | 2017 |
Publisher | Taylor & Francis |
Publisher_xml | – name: Taylor & Francis |
References | Leske MC (CIT0020) 2010; 27 Yonekawa Y (CIT0017) 1790; 2011 CIT0010 CIT0021 Congdon N (CIT0018) 2004; 122 CIT0012 CIT0011 CIT0022 Leske MC (CIT0014) 2004; 111 Early Treatment Diabetic Retinopathy Study Research Group (CIT0005) 1991; 98 CIT0003 CIT0002 CIT0013 CIT0016 CIT0015 CIT0007 CIT0006 CIT0009 Congdon N (CIT0004) 2001; 42 CIT0008 CIT0019 |
References_xml | – ident: CIT0016 doi: 10.1001/archopht.120.5.613 – ident: CIT0019 doi: 10.1016/j.ophtha.2012.11.041 – ident: CIT0021 doi: 10.1016/S0161-6420(01)00769-2 – volume: 27 start-page: 259 year: 2010 ident: CIT0020 publication-title: Causes of visual loss and their risk factors: an incidence summary from the Barbados Eye Studies. Rev Panam Salud Publica – ident: CIT0022 doi: 10.1111/1753-0407.12195 – ident: CIT0007 doi: 10.1016/S0039-6257(05)80092-X – ident: CIT0003 doi: 10.1038/eye.2012.94 – ident: CIT0008 doi: 10.1167/iovs.13-11911 – ident: CIT0006 doi: 10.1136/bjo.86.2.238 – ident: CIT0002 doi: 10.1093/ije/dys161 – ident: CIT0009 doi: 10.1111/j.1755-3768.2008.01445.x – volume: 2011 issue: 118 year: 1790 ident: CIT0017 publication-title: Ophthalmology – volume: 122 start-page: 487 year: 2004 ident: CIT0018 publication-title: Prevalence of cataract and pseudophakia/aphakia among adults in the United States. Arch Ophthalmol – volume: 111 start-page: 118 year: 2004 ident: CIT0014 publication-title: Four-year incidence of visual impairment: Barbados Incidence Study of Eye Diseases. Ophthalmology – ident: CIT0013 doi: 10.1016/S0161-6420(02)01898-5 – volume: 42 start-page: 2478 year: 2001 ident: CIT0004 publication-title: Invest Ophthalmol Vis Sci – volume: 98 start-page: 786 year: 1991 ident: CIT0005 publication-title: Grading diabetic retinopathy from stereoscopic color fundus photographs – an extension of the modified Airlie House classification – ident: CIT0015 doi: 10.1016/j.ophtha.2013.03.032 – ident: CIT0010 doi: 10.1016/j.ophtha.2010.09.032 – ident: CIT0011 doi: 10.1167/iovs.02-0457 – ident: CIT0012 doi: 10.1016/S0161-6420(02)01295-2 |
SSID | ssj0018056 |
Score | 2.161539 |
Snippet | Purpose: To study the 5-year incidence of visual impairment and its causes and risk factors, in the middle-aged Iranian sample of the Shahroud Eye Cohort Study... To study the 5-year incidence of visual impairment and its causes and risk factors, in the middle-aged Iranian sample of the Shahroud Eye Cohort Study (ShECS).... To study the 5-year incidence of visual impairment and its causes and risk factors, in the middle-aged Iranian sample of the Shahroud Eye Cohort Study... |
SourceID | proquest pubmed crossref informaworld |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 11 |
SubjectTerms | Adult Age Distribution Aged Aged, 80 and over Blindness Blindness - epidemiology Cohort Studies Female Humans Incidence Iran Iran - epidemiology longitudinal Male Middle Aged Multivariate Analysis Risk Factors Sex Distribution Vision, Low - epidemiology Visual Acuity visual impairment |
Title | Five-Year Incidence of Visual Impairment in Middle-Aged Iranians: The Shahroud Eye Cohort Study |
URI | https://www.tandfonline.com/doi/abs/10.1080/09286586.2016.1255342 https://www.ncbi.nlm.nih.gov/pubmed/27960616 https://www.proquest.com/docview/1852671735 |
Volume | 24 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bb9MwFLbKJiFeEHc2LjISb1WquIndZG8dtNqQAg90aDxFjuOQiDWZ0nTS-B_8X45j57YNjctLVDl1k_p8PuezfS4IvWUkdmIWM4vA3IEFCuWWx_zISgBdXmLb0qYq3jn4yI5O3A-n9HQ0-tnzWtpW0UT8uDGu5F-kCm0gVxUl-xeSbX8UGuAzyBeuIGG4_pGMl6CqrK8qFQ9Mc10dVJG_L9lGBYUcw0zPyvqwP8vHQb0TYc2_AcM8BgOVKQZtXC4-p1yV64nHi0tVxS4FSl47GA6OfD-dp1XKz5QvvezKyl52Kmyjcg_UpgwIeQe6QKYlv-Cl2WlNs4vWEizWfJ3p9qBI-XrN4yudl0VVbOu6w-P594iX_U0KMHz2wOFjda1eSH8jcupZwINMQmythmeuawF1ZH09rWOtB3jUStdoa22-deTmNcNgPCl9FYjrKdcUwibA7aijc3tdyblt7txBu1NYfYD63J0fvj9ctsdTnl2XBW5fvQkNU0nbb3rEgPQMUuL-fmFTE5zVA3TfrEzwXMPsIRrJ_BG6Gxjfi8cobNGGW7ThIsEabbhDG85y3EMbbtB2gAFruMEaBqxhjTVcY-0JOlkuVu-OLFOewxIOY5UFTFY6CayAZZxwyhIvYYRTKV1VGpFNhbCl8MGARAS-TqlwXZt7hBMSycT2hOM8RTt5kcvnCDu-zfzEk5GYETemJIqiOBYzWEtRb0oF3UNuM36hMLnrVQmVs5A0KW7NsIdq2EMz7Hto0nY718lbbuvg94UTVjVuEw3Z0Lml75tGkiGoaHXuxnNZbDehyk_AlLcL_I9nWsTt60xnaguBsP3_ePILdK-bcy_RTlVu5SugylX02gD3F8BLtYM |
linkProvider | EBSCOhost |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Five-Year+Incidence+of+Visual+Impairment+in+Middle-Aged+Iranians%3A+The+Shahroud+Eye+Cohort+Study&rft.jtitle=Ophthalmic+epidemiology&rft.au=Hashemi%2C+Hassan&rft.au=Mehravaran%2C+Shiva&rft.au=Emamian%2C+Mohammad+Hassan&rft.au=Fotouhi%2C+Akbar&rft.date=2017-02-01&rft.pub=Taylor+%26+Francis&rft.issn=0928-6586&rft.eissn=1744-5086&rft.volume=24&rft.issue=1&rft.spage=11&rft.epage=16&rft_id=info:doi/10.1080%2F09286586.2016.1255342&rft.externalDocID=1255342 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0928-6586&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0928-6586&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0928-6586&client=summon |